Travere Therapeutics, Inc. (TVTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.41B |
| Enterprise Value | 3.64B |
| P/E Ratio | -146.02 |
| PEG Ratio | 1.28 |
| Price/Sales Ratio | 10.33 |
| Price/Book Ratio | 250.49 |
| Enterprise/Revenue | 11.18 |
| Enterprise/EBITDA | 4,280.92 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.07 |
| Operating Margin | -0.07 |
| Return On Assets | -0.05 |
| Return On Equity | -0.56 |
| Revenue | 490.73M |
| Revenue/Share | 6.33 |
| Gross Profit | 480.39M |
| EBITDA | 22.22M |
| Net Income | -25.55M |
| Diluted EPS | -0.56 |
| Total Cash | 489.18M |
| Total Cash/Share | 5.23 |
| Total Debt | 616.91M |
| Total Debt/Equity | 25.16 |
| Current Ratio | 4.05 |
| Book Value Per Share | 0.26 |
| 52-Week Change | 266.69 |
| 52-Week High | 66.38 |
| 52-Week Low | 17.05 |
| Moving Average 50 Days | 57.9 |
| Moving Average 200 Days | 40.82 |
| Average Volume | 1.87M |
| Shares Outstanding | 92.99M |
| % Held by Institutions | 115.32 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:9 |
| Last Split Date | November 02, 2012 |